Bright Vision Sponsor LLC - Oct 26, 2021 Form 3 Insider Report for Deep Medicine Acquisition Corp. (DMAQ)

Role
10%+ Owner
Signature
/s/ Ke Li, as the Managing Member of Bright Vision Sponsor LLC
Stock symbol
DMAQ
Transactions as of
Oct 26, 2021
Transactions value $
$0
Form type
3
Date filed
10/26/2021, 08:34 PM
Next filing
Nov 2, 2021

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding DMAQ Class B Common Stock Oct 26, 2021 Class A Common Stock 3.16M Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 As described in the registrant's registration statement on Form S-1 (File No. 333-259500) under the heading "Description of Securities - Founder Shares", the shares of Class B common stock will automatically convert into shares of Class A common stock at the time of the registrant's initial business combination, or earlier at the option of the holder, on a one-for-one basis subject to certain adjustments and have no expiration date.
F2 These shares represent shares of the Class B common stock held by Bright Vision Sponsor LLC (the "Sponsor"), acquired pursuant to a securities subscription agreement by and between the Sponsor and the registrant. The Class B common stock owned by the Sponsor includes up to 412,500 shares that are subject to forfeiture in the event the underwriters of the initial public offering of the registrant's securities do not exercise in full their over-allotment option as described in the registrant's registration statement on Form S-1. Mr. Ke Li is the managing member of the Sponsor and may be deemed the beneficial owner of the shares held by the Sponsor. Mr. Ke Li disclaims beneficial ownership over any securities in which she does not have a pecuniary interest.